Bugatone

Company Overview

Snapshot

Founded in February 2013 by Edmund Ben Ami and Noam Petrank, Bugatone operated with 1–10 employees. The company secured funding across three rounds from four investors. In December 2017, Bugatone received investment from Oppo and Wellborn Ventures.

Business overview

Bugatone develops software designed to enhance earphone capabilities, focusing on improving audio quality through active noise cancellation and enabling vital sign measurement. The company's core technology utilizes a sonar-like device that emits imperceptible sound waves into the ear canal to interpret returning signals. Bugatone operates within the Health Tech & Life Sciences sector, specifically targeting the digital healthcare market with solutions for patient remote monitoring and consumer wellness.

Strategic signal

In December 2017, Bugatone received investment from Oppo, a significant player in consumer electronics. This investment signaled a potential strategic validation of Bugatone's earphone-enhancing software and its underlying sonar technology, suggesting interest from major industry players in integrating advanced audio and biometric capabilities into their product lines.

Company Intelligence Q&A

What is Bugatone's primary technology?

Bugatone's core technology operates like a sonar device, sending imperceptible sound waves into the ear canal and interpreting the returning signals to enhance earphone capabilities and measure vital signs.

When was Bugatone founded and by whom?

Bugatone was founded in February 2013 by Edmund Ben Ami and Noam Petrank.

What was Bugatone's status as of February 2021?

As of February 2021, Bugatone ceased to operate and is classified as Non Active.

Which investors participated in Bugatone's June 2015 funding round?

In June 2015, Bugatone received investment from Wellborn Ventures, Maya Liquornik, and Alon Sahar.